(Q34569986)

3 August 2017

1 reference

title

Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review (English)

1 reference

positron emission tomography

3 August 2017

main subject

0 references

0 references

3

L Højgaard

0 references

Jann Mortensen

object named as

J Mortensen

series ordinal

2

0 references

author name string

B M Fischer

series ordinal

1

1 reference

3 August 2017

publication date

1 November 2001

1 reference

Lancet Oncology Commission

3 August 2017

published in

1 reference

3 August 2017

volume

2

1 reference

3 August 2017

issue

11

1 reference

3 August 2017

page(s)

659-666

1 reference

Incidence of lung cancer in Denmark: historical and actual status

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Applications of PET in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Positron emission tomography in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

PET scans approved for detecting metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Bias in location and selection of studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Positron emission tomographic imaging with fluorodeoxyglucose isefficacious in evaluating malignant pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Localized form of bronchioloalveolar carcinoma: FDG PET findings

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Prospective investigation of positron emission tomography in lung nodules

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Controlled prospective study of positron emission tomography using the glucose analogue [18F]fluorodeoxyglucose in the evaluation of pulmonary nodules

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Pulmonary abnormalities and PET data analysis: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Evaluation of the solitary pulmonary nodule by positron emission tomography imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Characterization of pulmonary nodules and mediastinal staging of bronchogenic carcinoma with F-18 fluorodeoxyglucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Characterization of chest masses by FDG positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Improvement of non-small-cell lung cancer staging by means of positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Selective use of PET scan in the preoperative staging of NSCLC

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Detection of extrathoracic metastases by positron emission tomography in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Mediastinal staging of non-small-cell lung cancer with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Staging non-small cell lung cancer by whole-body positron emission tomographic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

[Brain metastases of lung cancer: diagnostic accuracy of positron emission tomography with fluorodeoxyglucose (FDG-PET)]

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Imaging of lung cancer with fluorine-18 fluorodeoxyglucose: comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Staging of lymph nodes with FDG dual-headed PET in patients with non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

FDG SPECT in patients with lung masses

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Can dual-headed 18F-FDG SPET imaging reliably supersede PET in clinical oncology? A comparative study in lung and gastrointestinal tract cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Pulmonary nodules: differential diagnosis using 18F-fluorodeoxyglucose single-photon emission computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Preoperative staging of non-small-cell lung cancer with positron-emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Analytical decision model for the cost-effective management of solitary pulmonary nodules.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Cost-effectiveness of whole-body PET imaging in non-small cell lung cancer and malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900555-1

7 January 2021

10.1016/S1470-2045(01)00555-1

Identifiers

DOI

1 reference

release_36c7jffthfds5agbn7cgjc5una

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/36c7jffthfds5agbn7cgjc5una

24 November 2022

mapped directly with Wikidata item

1 reference